ArticleInternational journal of clinical oncology2025
Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study.
Kenji Morimoto et al.PubMed ↗Publisher ↗
No numbers read from the abstract.